Chemoinformaics analysis of medicagenic-acid
| Molecular Weight | 245.322 | nRot | 2 |
| Heavy Atom Molecular Weight | 226.17 | nRig | 0 |
| Exact Molecular Weight | 245.142 | nRing | 3 |
| Solubility: LogS | -5.926 | nHRing | 2 |
| Solubility: LogP | 5.86 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 40.4231 |
| nHD | 0 | BPOL | 23.3749 |
| QED | 0.479 |
| Synth | 2.218 |
| Natural Product Likeliness | 1.041 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.331 |
| MDCK | 0.0000129 |
| BBB | 0.613 |
| PPB | 0.974362 |
| VDSS | 3.009 |
| FU | 0.0248812 |
| CYP1A2-inh | 0.933 |
| CYP1A2-sub | 0.429 |
| CYP2c19-inh | 0.555 |
| CYP2c19-sub | 0.701 |
| CYP2c9-inh | 0.452 |
| CYP2c9-sub | 0.887 |
| CYP2d6-inh | 0.097 |
| CYP2d6-sub | 0.093 |
| CYP3a4-inh | 0.096 |
| CYP3a4-sub | 0.117 |
| CL | 6.572 |
| T12 | 0.171 |
| hERG | 0.058 |
| Ames | 0.006 |
| ROA | 0.041 |
| SkinSen | 0.863 |
| Carcinogencity | 0.052 |
| EI | 0.975 |
| Respiratory | 0.465 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.789121 |